Fundraising Fox

Mediar Therapeutics

Boston, US · Founded 2018 · Delaware corporation · 9 known investors

mediartx.com ↗

Mediartx develops novel therapies for patients with fibrotic diseases.

BiotechMedical Devicesin /mediar-therapeutics

Founders & leadership

RB
Rahul Ballal, PhDCEO
PY
Paul Yaworsky, PhDinCSO
RB
Rahul BallalExecutive Officer, Director
BH
Brian HubbardDirector
SB
Stacey BrennerExecutive Officer
DD
David de GraafDirector
MB
Michael BaranDirector
MF
Meredith FisherDirector
AJ
Andreas JurgeitDirector
AK
Anja KonigDirector
CB
Cassidy BlundellDirector
MB
Maina BhamanDirector

Investors · 9

Longwood FundBoston
Mission BiocapitalSan Francisco · $500K
Novartis Venture FundBasel · $5M – $25Mvia Anja Koenig · board
Ono Venture Investment, Inc.South San Francisco
Pfizer Venture Investments$5M – $20M
ShangBay Capital LLCPalo Alto
Sofinnova PartnersParis · $540K – $27Mvia Maina Bhaman · board
Agent CapitalreportedWaltham
Pfizer Venturesreported

Reported raises · per SEC filings

Form D private placements
▶$37.8MraisedDec 2025 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andreas JurgeitDirector
  • Bharat SrinivasaDirector
  • Allan MarchingtonDirector
  • Rahul BallalExecutive Officer, Director
  • Cassidy BlundellDirector
  • Maina BhamanDirector
  • Adam CottonDirector
  • Simon SturgeDirector
  • Marie-Claire PeakmanDirector
Offering amount
$75.7M
Amount sold
$37.8M
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$85MraisedOct 2024 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Simon SturgeDirector
  • Michael BaranDirector
  • Meredith FisherDirector
  • Andreas JurgeitDirector
  • Anja KonigDirector
  • Rahul BallalExecutive Officer, Director
  • Cassidy BlundellDirector
  • Maina BhamanDirector
Offering amount
$85M
Amount sold
$85M
First sale
Nov 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedFeb 2019 · 7 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian HubbardDirector
  • Stacey BrennerExecutive Officer
  • Peter ParkerDirector
  • David de GraafDirector
  • Meredith FisherDirector
Offering amount
$10M
Amount sold
$5M
First sale
Jan 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news